Zobrazeno 1 - 10
of 26
pro vyhledávání: '"Haruka, Ishida"'
Autor:
Chuang Ma, Makoto Izumiya, Hidehiko Nobuoka, Rintaro Ueno, Masaki Mimura, Katsuya Ueda, Haruka Ishida, Daihachiro Tomotsune, Kohei Johkura, Fengming Yue, Naoto Saito, Hisao Haniu
Publikováno v:
Nanomaterials, Vol 14, Iss 3, p 251 (2024)
The progress in artificial bone research is crucial for addressing fractures and bone defects in the aging population. However, challenges persist in terms of biocompatibility and structural complexity. Nanotechnology provides a promising avenue by w
Externí odkaz:
https://doaj.org/article/a8ba34acf29c4f1b9c0420908968f2a9
Autor:
Katsuya Ueda, Chuang Ma, Makoto Izumiya, Chika Kuroda, Haruka Ishida, Takeshi Uemura, Naoto Saito, Kaoru Aoki, Hisao Haniu
Publikováno v:
Nanomaterials, Vol 13, Iss 2, p 244 (2023)
With the advent of nanotechnology, the use of nanoparticles as drug delivery system (DDS) has attracted great interest. We aimed to apply carbon nanohorns (CNHs) as DDS in the development of new treatments for bone diseases. We evaluated the in vitro
Externí odkaz:
https://doaj.org/article/9d9281bec40c44498445c7703326a8d9
Autor:
Kazushige Yoshida, Masanori Okamoto, Jun Sasaki, Chika Kuroda, Haruka Ishida, Katsuya Ueda, Hirokazu Ideta, Takayuki Kamanaka, Atsushi Sobajima, Takashi Takizawa, Manabu Tanaka, Kaoru Aoki, Takeshi Uemura, Hiroyuki Kato, Hisao Haniu, Naoto Saito
Publikováno v:
BMC Cancer, Vol 20, Iss 1, Pp 1-10 (2020)
Abstract Background There are many types of therapies for cancer. In these days, immunotherapies, especially immune checkpoint inhibitors, are focused on. Though many types of immune checkpoint inhibitors are there, the difference of effect and its m
Externí odkaz:
https://doaj.org/article/8b454d0963554609b62f3cea9028c887
Publikováno v:
Journal of the Japan Institute of Energy. 101:258-264
Autor:
Mahoko Sano, Makoto Izumiya, Hisao Haniu, Katsuya Ueda, Kosuke Konishi, Haruka Ishida, Chika Kuroda, Takeshi Uemura, Kaoru Aoki, Yoshikazu Matsuda, Naoto Saito
Publikováno v:
Nanomaterials, Vol 10, Iss 7, p 1374 (2020)
One of the greatest challenges to overcome in the pursuit of the medical application of carbon nanomaterials (CNMs) is safety. Particularly, when considering the use of CNMs in drug delivery systems (DDSs), evaluation of safety at the accumulation si
Externí odkaz:
https://doaj.org/article/1dc8285dce5243c2810d87eb60131be4
Autor:
Sachiyo Ozawa, Haruka Ishida, Tomomi Iwatani, Hitomi Hirose, Katsuharu Tsuchida, Uraka Matsumoto
Publikováno v:
Pharmacology. 106:91-105
Background/Aims: Monensin, an Na ionophore, increases intracellular Na ([Na]i). Alteration of [Na]i influences ion transport through the sarcolemmal membrane. So far, the effects of monensin on ventricular myocytes have not been examined in detail. T
Publikováno v:
Japanese Journal of Applied Physics. 62:015501
Thermodynamic analyses of β-Ga2O3 growth by both ozone and plasma-assisted molecular beam epitaxy (MBE) were performed. In either case, the growth mechanism was found to differ depending on whether the input VI/III ratio was above or below 1.5. Unde
Autor:
Haruka Ishida, Takayuki Kamanaka, Takeshi Uemura, Katsuya Ueda, Manabu Tanaka, Hiroyuki Kato, Hisao Haniu, Naoto Saito, Yoong Ahm Kim, Masanori Okamoto, Atsushi Sobajima, Takashi Takizawa, Kaoru Aoki, Jin Hee Kim, Hirokazu Ideta, Kazushige Yoshida, Tetsuhiko Mimura
Publikováno v:
RSC Advances. 10:33071-33079
When cancer metastasizes to bone, the resulting pain and functional disorders due to bone destruction adversely affect the patient's quality of life. We have developed a new cancer metastasis control system consisting of anticancer agents conjugated
Autor:
Katsuya Ueda, Haruka Ishida, Satomi Okano, Hiroki Nomura, Hisao Haniu, Takayuki Kamanaka, Kumiko Ajima, Takashi Takizawa, Naoto Saito, Jun Sasaki, Kazushige Yoshida, Manabu Tanaka, Kaoru Aoki, Masanori Okamoto, Atsushi Sobajima, Hiroyuki Kato, Chika Kuroda
Publikováno v:
International Journal of Nanomedicine. 14:6465-6480
Purpose Multiwalled carbon nanotubes (MWCNTs) have been known to enter the circulatory system via the lungs from inhalation exposure; however, its carcinogenicity and subsequent accumulation in other organs have not been adequately reported in the li
Autor:
Masanori Okamoto, Chika Kuroda, Atsushi Sobajima, Hisao Haniu, Naoto Saito, Jun Sasaki, Kaoru Aoki, Kazushige Yoshida, Takeshi Uemura, Haruka Ishida, Hiroyuki Kato, Katsuya Ueda, Takayuki Kamanaka, Satomi Okano, Munehisa Kito, Takashi Takizawa, Hirokazu Ideta
Publikováno v:
OncoTargets and Therapy. 12:2513-2518
Purpose Although both anti-PD-1 antibody and treatments using anti-PD-L1 antibody are currently in clinical use, their therapeutic effects vary according to cancer type. One of the factors accounting for this variability is the expression level of th